Comparison of estimated glomerular filtration rate of marginal versus standard renal allograft: A prospective cohort study.

INTRODUCTION: The end-stage renal disease (ESRD) population is increasing worldwide and organ shortage is an important issue. The disparity between the availability of organs and waitlisted patients for transplants has forced many transplant centers across the world to use marginal kidney donors. We assess and compare postoperative estimated glomerular filtration rate (eGFR) in patients who received a graft from marginal renal donor (MRD) versus those who received a graft from standard renal donor (SRD). METHODS: A total of 214 patients with ESRD underwent open live donor renal allografting from September 2015 to September 2017. Out of 214 donors, 165 (77.1%) were SRD and 49 (22.9%) were MRD. Post-transplant eGFR was calculated at 2 months for donors and at days 1, 3, 5, and 7 and month 1, 3, 6, and 12 for recipients. RESULTS: There was no statistically significant difference in eGFR of recipients at preoperative and postoperative period between SRD and MRD groups. Although at 12 months of follow-up eGFR was relatively high in SRD group, it did not show any statistically significant difference. The recipient survival rate at 1-year follow-up was 98.2% in SRD and 100% in MRD group. CONCLUSIONS: Renal transplant recipients using MRDs have a comparable glomerular filtration rate to SRDs at the end of 1 year. Short-term outcomes in recipients receiving marginal renal grafts were similar when compared to the allograft from standard donors.

Multiparametric magnetic resonance imaging-transrectal ultrasound fusion prostate biopsy: A prospective, single centre study.

INTRODUCTION: Transrectal rectal ultrasound (TRUS)-guided systematic biopsy is the gold standard for diagnosis of prostate cancer. However, systematic biopsy has high false-negative rate and often misses anteriorly located tumors. Magnetic resonance imaging (MRI)-TRUS fusion biopsy can potentially improve cancer detection by better visualization and targeting of cancer focus. We evaluated the role of fusion biopsy in detection of prostate cancer and the association of prostate imaging reporting and data system (PI-RADS) score for predicting cancer risk and its aggression. METHODS: Ninety-six consecutive men with suspected prostate cancer underwent MRI-TRUS fusion-targeted biopsy of suspicious lesions and standard 12 core biopsy from May 2014 to July 2015 in our institution. All patients underwent 3.0 T multiparametric MRI before biopsy. mp-MRI included T2W, DWI, DCE and MRS sequences to identify lesions suspicious for prostate cancer. Suspected lesions were scored according to PI-RADS scoring system. Comparison of cancer detection between standard 12 core biopsy and MRI-TRUS fusion biopsy was done. Detection of prostate cancer was primary end point of this study. RESULTS: Mean age was 64.4 years and median prostate-specific antigen was 8.6 ng/ml. Prostate cancer was detected in 57 patients (59.3%). Of these 57 patients, 8 patients (14%) were detected by standard 12 core biopsy only, 7 patients (12.3%) with MRI-TRUS fusion biopsy only, and 42 patients (73.7%) by both techniques. Of the 7 patients, detected with MRI-TRUS fusion biopsy alone, 6 patients (85.7%) had Gleason ≥7 disease. Prostate cancer was detected on either standard 12 core biopsy or MRI-TRUS fusion biopsy in 0%, 42.8%, 74%, and 89.3% patients of suspicious lesions of highest PI-RADS score 2, 3, 4, and 5, respectively. CONCLUSIONS: MRI-TRUS fusion prostate biopsy improves cancer detection rate when combined with standard 12 cores biopsy and detects more intermediate or high-grade prostate cancer (Gleason ≥7). With increasing PI-RADS score, there is an increase chance of detection of cancer as well as its aggressiveness.

Predictive factors for lymph node positivity in patients undergoing extended pelvic lymphadenectomy during robot assisted radical prostatectomy.

INTRODUCTION: Pelvic lymphadenectomy during radical prostatectomy (RP) improves staging and may provide a therapeutic benefit. However, there is no clear consensus on the selection criteria for subjecting patients to this additional procedure. With a growing adoption of robot assisted radical prostatectomy (RARP) in India, it has become imperative to study the incidence and predictive factors for lymph node involvement in our patients. MATERIALS AND METHODS: From February 2010 to February 2014, 452 RARP procedures were performed at our institution. A total of 100 consecutive patients from July 2011 to August 2012 were additionally subjected to a robotic extended pelvic lymphadenectomy (EPLND). Lymph node positivity rates and lymph node density were analyzed on the basis of preoperative prostate specific antigen (PSA), Gleason score, clinical stage, D'Amico risk category and magnetic resonance imaging (MRI) findings. Multivariate analysis was performed to ascertain factors associated with lymph node positivity in our cohort. RESULTS: The mean age of the patients was 65.5 (47-77) years and the body mass index was 26.3 (16.3-38.7) kg/m(2). The mean console time for EPLND was 45 (32-68) min. A median of 17 (two to 40) lymph nodes were retrieved. Seventeen patients (17%) had positive lymph nodes (median of 1, range 1-6). Median lymph node density in these patients was 10%. When stratified by PSA, Gleason score, clinical stage, D'Amico risk category and features of locally advanced disease on MRI, a trend towards increasing incidence of lymph node positivity was observed, with an increase in adverse factors. However, on multivariate analysis, clinical stage > T2a was the only significant factor impacting lymph node positivity in our cohort. CONCLUSIONS: A significant proportion of men undergoing RARP in India have positive lymph nodes on EPLND. While other variables may also have a potential impact, a higher clinical stage predisposes to an increased incidence of lymph node metastases.

Preoperative Predictors of Extraprostatic Extension of Prostate Cancer (pT3a) in a Contemporary Indian Cohort.

We present our experience with robotic radical prostatectomy and analyse the predictors for extracapsular extension (EPE) in a cohort of Indian patients. Four hundred fifty-three patients underwent robotic radical prostatectomy from May 2010 to October 2015. Post hoc analysis of prospectively maintained data was done. Multivariable regression analysis was used on variables which had significant association with EPE on univariable analysis. Receiver operating characteristic (ROC) curves were plotted for the independent predictors of EPE. Mean age was 64.62 ± 6.44 years. Mean BMI 26.03 ± 4.01 kg/m2. Median prostate-specific antigen (PSA) was 13.38 ng/ml (IQR 8.1-23.5). Seventy-seven (16.99%) patients had Gleason >7. Mean core positivity (percentage of cores positive) was 48,93 ± 27.29% and mean maximum percentage of tumour in a core was 33,04 ± 31.16%. Positive surgical margins were present in 141/453 (31.15%). Lymph nodes were positive in 21.2% of those who had nodes removed (77/364). Maximum cancer in a core (p < 0.001), core positivity (p = 0.002) and Gleason score ≥4 + 3 (p = 0.028) were significant predictors of EPE, independent of BMI, PSA, PNI and clinical stage. Receiver operating characteristic (ROC) analysis for core positivity showed an area under the curve (AUC) of 0.775, and a 76% core positivity predicted EPE with a sensitivity of 65% and a specificity of 87.1%, respectively. ROC curve for maximum cancer in a core showed an area under the curve of 0.898. Seventy per cent cancer in a single core predicted EPE with a sensitivity of 80.6% and a specificity of 85.9% Indian patients present with more advanced disease, higher PSA and have higher incidence of EPE. Maximum cancer in a core, ratio of positive cores and Gleason score ≥4 + 3 are predictors of EPE independent of PSA and clinical stage.

Robot-Assisted Simultaneous Bilateral Radical Inguinal Lymphadenectomy Along with Robotic Bilateral Pelvic Lymphadenectomy: A Feasibility Study.

INTRODUCTION: To report the surgical technique, procedure outcomes, and feasibility of robot-assisted simultaneous bilateral radical inguinal with bilateral pelvic lymphadenectomy. MATERIALS AND METHODS: Three consecutive patients of penile and urethral carcinoma with palpable inguinal lymphadenopathy who underwent robot-assisted simultaneous bilateral radical inguinal with bilateral pelvic lymphadenectomy in our institution from May 2013 to October 2015 were included in the study. Surgical technique is described and feasibility of the procedure is assessed. RESULTS: Three patients aged 58, 76, and 35 years underwent robot-assisted simultaneous bilateral radical inguinal with bilateral pelvic lymphadenectomy with a mean operative duration of 453.33 minutes (range 420-490 minutes). Average blood loss was 66.66 mL (range 50-80 mL) and mean time to removal of last drain was 44.66 days (range 28-72 days). Mean lymph node yield in left inguinal region, right inguinal region, left pelvic region, and right pelvic region was 18, 14.6, 13.3, and 16.6, respectively. The perioperative period was uneventful. No skin flap-related complications were seen. One patient suffered lymphocele postoperatively, which was managed successfully with needle aspiration. One patient developed lung metastasis in follow-up and none of them had local recurrence. CONCLUSION: Robot-assisted simultaneous bilateral radical inguinal with bilateral pelvic lymphadenectomy is feasible, safe, and may result in decreased morbidity compared to conventional open lymphadenectomy.

Laparoscopic pyeloplasty using the postanastomotic dismemberment method: technique and results.

BACKGROUND AND PURPOSE: Despite excellent results, widespread acceptance of the laparoscopic dismembered Anderson-Hynes pyeloplasty (AH) is hampered by its steep learning curve. Laparoscopic nondismembered pyeloplasty techniques, although simpler, have not matched the results of AH. We have been using a technical modification of AH to combine its excellent outcome with technical ease of nondismembered pyeloplasties. We describe the procedure and results of laparoscopic postanastomotic dismemberment (PAD) pyeloplasty for primary ureteropelvic junction (UPJ) obstruction. PATIENTS AND METHODS: PAD technique involves an initial partial division of the dilated pelvis and ureteral spatulation without dismembering the UPJ. Both layers of ureteropelvic anastomosis are completed before dismemberment and pelvic reduction. Forty-one PAD procedures in 40 patients with UPJ obstruction and follow-up of at least 3 months were evaluated. Mean age was 37.2 years (range 2-82 years) with 22 patients younger than 15 years. The UPJ was dependent in 31 and had high insertion in 10 (24.4%). The stenotic segment was long (> or =1.5 cm) in 18 (43.9%). Crossing vessels and secondary calculi were observed in six (14.6%) and seven (17.1%) units. RESULTS: Mean (+/- SD) blood loss, hospital stay, convalescence, and analgesia requirement were 68.1 +/- 37.6 mL, 3.8 +/- 1.1 days, 11.4 +/- 3.9 days, and 204.8 +/- 60.5 mg diclofenac, respectively. The mean operative time was 97.6 +/- 22.1 minutes. There was one intraoperative complication in the form of injury to a renal vein tributary, with no transfusions or conversions. Postoperative complications included pain after stent removal, persistent drainage, and pyelonephritis in 1, 2, and 4 patients, respectively. Mean follow-up was 19.5 months (range 3-58 months), with a success rate of 95.1%. Failures were not attributable to UPJ configuration, length of stenosis, or age. CONCLUSIONS: The PAD technique has several practical advantages with a shorter operative time compared with other historical series of laparoscopic pyeloplasty (LP). It combines the ease of nondismembered LP with the excellent outcome of dismembered techniques.